Generate:Biomedicines shares early Phase 1 respiratory data after ERS poster leak

Generate:Biomedicines presented Phase 1 data for its respiratory disease candidate at the European Respiratory Society annual meeting. The presentation came after the conference posters were released two weeks early, prompting the company to disclose the information ahead of schedule.

The early release was not part of the original plan; the company had intended to unveil the data at the scheduled session. The premature poster leak forced a rapid response to ensure stakeholders received accurate details directly from the company.

No efficacy or safety outcomes were highlighted in the brief release, and the company indicated that full results will be shared in a formal setting later this year as the trial progresses.

Generate:Biomedicines reaffirmed its commitment to advancing the respiratory program despite the unexpected disclosure, emphasizing continued development and upcoming milestones.